Merits of a new drug trial for ALS?

Science. 2005 Apr 29;308(5722):632-3; author reply 632-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amino Acid Transport System X-AG / biosynthesis
  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Biological Transport / drug effects
  • Ceftriaxone / pharmacology
  • Ceftriaxone / therapeutic use*
  • Clinical Trials as Topic
  • Glutamic Acid / metabolism
  • Humans
  • Rats
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism

Substances

  • Amino Acid Transport System X-AG
  • Anti-Bacterial Agents
  • Glutamic Acid
  • Ceftriaxone